Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway
Journal of Clinical Oncology - United States
doi 10.1200/jco.2011.39.7356
Full Text
Open PDFAbstract
Available in full text
Date
August 10, 2012
Authors
Publisher
American Society of Clinical Oncology (ASCO)